PRETELL: PREvention of TELomere-related Complications After Lung Transplant
Status:
Not yet recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of Danzol in lung transplant recipients with short
telomeres.
Subjects with short telomeres recipient of lung transplant, will be randomized in the first
month post-transplant to either placebo or Danazol (200mg bid) in a 2:1 ratio.